The Media’s Embarrassing Failure to Bring Up Obamacare in
The Media’s Embarrassing Failure to Bring Up Obamacare in the Debates
Maybe Bill Clinton should moderate Sunday’s presidential debate. Referring to Obamacare this week as “the craziest thing in the world,” he seems to understand that the consequences of the health care law might be of interest to voters.
Indeed, according to a recent Pew Research Center poll, 71 percent of Donald Trump supporters and 77 percent of Hillary Clinton supporters say the issue of health care is “very important” to their vote in 2016.
Which is why it seems odd that not one single question dealing with Obamacare was asked at either the first presidential debate or the only vice presidential debate of the 2016 election. Not one.
Well, perhaps it’s only odd if you don’t know the major broadcast networks have all but ignored the disastrous news stories about Obamacare.
According to the media watchdogs over at the Media Research Center, from Jan. 1 through Aug. 31, ABC’s “World News Tonight” and “NBC Nightly News” have not covered the issue at all. “CBS Evening News” dedicated a whopping 2 minutes and 18 seconds to the subject.
As the Media Research Center notes, “To put that in perspective, these same three evening news shows managed to find 46 minutes and 49 seconds to dedicate to Olympic swimmer Ryan Lochte running afoul of Brazilian police.”
Maybe we’ll get a question about Lochte in the next debate.
There are so many questions that could be posited about Obamacare’s failures that perhaps the moderators just haven’t been able to choose which one to ask. For example:
Sir/Madame: The Government Accountability Office just announced last week that its investigation has determined that Health and Human Services has been illegally bailing out insurance companies with taxpayer dollars. What’s your reaction?
Or …
Sir/Madame: What do you say to the hundreds of thousands of Americans who have lost the insurance they bought through Obamacare’s public co-ops? So far, 12 of the 23 co-ops have failed and been shut down, costing taxpayers $1.2 billion and forcing 740,000 people in 14 states to scramble to find new health insurance.
Or …
Sir/Madame: Contrary to what President Barack Obama originally promised, many Americans’ premiums did not go down, they’ve gone up. And the evidence suggests they will continue to rise. By 2025, the Congressional Budget Office predicts that employment-based coverage will cost about 60 percent more than it does today because of Obamacare. How will you address that?
Or … (my personal favorite)
Sir/Madame: Former President Bill Clinton referred to Obamacare as “the craziest thing in the world.” Do you agree with his remarks?
So many options but not one single question in either debate on the topic.
And yet, abortion, which fewer than half of voters say is very important to their vote, was a major topic in the vice presidential debate.
And I’m not saying it isn’t important. But why did CBS moderator Elaine Quijano think it was more important to voters than the issue of health care?
If she’d done a little more homework, she might have been able to combine the two issues by asking what the candidates thought about a report from the Government Accountability Office showing that Obamacare forces taxpayers to subsidize bills for abortion services.
One might think that, in the post-debate analysis, some in the media might start asking about what major issues have not been addressed.
The folks over at NBC News apparently did ask that question but got the wrong answer.
An article following the vice presidential debate said the debate “left lesbian, gay, bisexual, and transgender advocates stunned, after 90 minutes of questioning failed to address a single LGBTQ issue.”
It doesn’t mention that voters rank that issue over 30 percentage points behind health care as important to their vote.
To say the media doesn’t get it lets them off the hook way too easy. They get it all right. Obamacare is a disaster but they’re hoping voters won’t notice.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
When the Trust Breaks October 29, 2026 was a gut punch for Xerox investors. Watching the outlook dive by $130 million, the coffee-feeling in the trading rooms turned into something more bitter. A $105 million boost they once celebrated from tariff receivables now seems to be a fleeting shadow, as Xerox itself scuttles its adjusted operating income for 2026 to a range of...
Continue Reading
Gaming Audio Gets a Power Boost with X60 We're diving headfirst into an era where gaming headsets promise more bells and whistles than ever before. This isn't just some random gadget plopped on the market. ATTACK SHARK's X60 Gaming Headset is strutting in, guns blazing, ready to take on the heavyweights in the competitive gaming world. It's not just about being another...
Continue Reading
A Month of Patriotism and Service You've got to hand it to the Daughters of the American Revolution (DAR)—when they commit, they go all in. This year, they turned their usual Day of Service into a full-blown Month of Service, packing in over 587,000 hours of volunteering nationwide. From historic spots to food pantries, DAR members showed up, and honestly, it's the kind...
Continue Reading
A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...
Continue Reading
A Fresh Start for Peapack-Gladstone's Corporate Relic Dust off the pages of history—Peapack-Gladstone's old Pfizer/Beneficial Finance campus is getting a makeover, and boy, it’s not your run-of-the-mill renovation. We're talking adaptive reuse to the tune of nearly $200 million, morphing this architectural gem into CopperWood Senior Living. With all the office...
Continue Reading
Pozdeutinurad's Phase 3 Triumph Ah, the life of biotech—constant ups and downs, but when you hit a homerun, it feels like the market stands still for a second. Pozdeutinurad's recent Phase 3 REDUCE-2 study results are one of those moments for Swedish Orphan Biovitrum AB, or Sobi for short. This study showed some seriously compelling data: clinically meaningful and...
Continue Reading
Crafting Stories with Precision: Cornue's Return In the world where Austin becomes a melting pot of ideas every spring, the return of David Cornue to SXSW casts a familiar, yet electrifying spark. This best-selling author and television whiz is slated to share his story magic at two workshops: one in the Lifestyle track and the other in the Film & TV track. Folks on-site...
Continue Reading
Tech Talk: LanguageLine's AI App Gains Important Recognition Diving headfirst into the chaotic world of healthcare, LanguageLine's AI Translation App earned a standout accolade. Just announced, it's snagged the Innovative Technology Designation from Vizient, the heavyweight champ in healthcare performance improvement. On the scene since the end of October, they rolled the...
Continue Reading
Microsoft's Stamp of Approval for Ashling Ah, recognition—it's not just for egos. When Ashling, an AI consultancy heavyweight, gets a nod from Microsoft, it's worth more than a footnote in the company newsletter. This isn't some participation trophy. Nope, it's a badge saying they know their Data & AI, and Digital & App Innovation inside out. On October 29, 2026,...
Continue Reading
Maison Martell Dances to a New Beat The world's oldest cognac house, Maison Martell, is mixing things up in a way that’ll make your typical whiskey-on-the-rocks seem like child’s play. They've snagged Afrobeat heavyweight Davido and renowned visual poet Prince Gyasi to spin a fresh narrative, one where melody and imagery play in harmony. While this ain't your usual...
Continue Reading
Top 5 Most Recently Viewed Articles
RXO, Inc. Facilitates Resale of Common Stock RXO, Inc. (NYSE: RXO), a notable player in the transportation services sector, has taken an important step by filing a prospectus with the Securities and Exchange Commission (SEC). This prospectus outlines the plan for the resale of common stock by certain stockholders, allowing them access to the public market for their...
Continue Reading
Dendi and Molecular Lab Partners Forge Strategic Alliance Dendi, a prominent provider of cloud-native laboratory information systems, is joining forces with Molecular Lab Partners (MLP), a consultancy known for its high-complexity lab implementations. This strategic partnership aims to revolutionize the landscape of in-house clinical labs. By merging Dendi's innovative...
Continue Reading
Anticipated Earnings Release for Orla Mining Orla Mining (AMEX: ORLA) is set to unveil its quarterly earnings, and investors are keenly observing the upcoming report. Analysts are projecting the company will announce an earnings per share (EPS) of $0.20, which generates a mix of anticipation and excitement in the market. Insights Into Previous Earnings Performance In the...
Continue Reading
What's Happening with Intuitive Machines Stock? Intuitive Machines, Inc. (NASDAQ: LUNR) has been experiencing a positive trading session recently. Analysts from Clear Street have maintained a favorable outlook, giving a Buy rating and increasing the target price from $17 to $25. Factors Behind the Positive Outlook Clear Street's outlook was influenced by Intuitive...
Continue Reading
AdvanSix Receives $12 Million USDA Grant AdvanSix (NYSE: ASIX), a notable company in the diverse chemistry industry, has made an exciting announcement. The firm is set to receive a significant grant of $12 million from the U.S. Department of Agriculture (USDA) to enhance its production of granular ammonium sulfate. This financial support is part of the USDA's Fertilizer...
Continue Reading